Mereo BioPharma Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
CEODenise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees36
Employees36
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees36
Employees36
MREO Key Statistics
Market cap66.06M
Market cap66.06M
Price-Earnings ratio-1.67
Price-Earnings ratio-1.67
Dividend yield—
Dividend yield—
Average volume8.73M
Average volume8.73M
High today$0.455
High today$0.455
Low today$0.41
Low today$0.41
Open price$0.4416
Open price$0.4416
Volume2.16M
Volume2.16M
52 Week high$3.26
52 Week high$3.26
52 Week low$0.20
52 Week low$0.20
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
25%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.